摘要
全世界糖尿病(diabetes mellitus, DM)的患病率急剧增加,高血糖的损害作用分为微血管并发症(糖尿病肾病、神经病变和视网膜病变)和大血管并发症(冠状动脉疾病、外周动脉疾病和中风),大量研究表明单核细胞/高密度脂蛋白胆固醇比值(MHR)是炎症指标,MHR具有简单易测和稳定性等优点,未来可能成为糖尿病微血管病变及大血管并发症的预测因子。本文就MHR在2型糖尿病中作用的研究进展作一综述。
The prevalence of diabetes mellitus (DM) has increased dramatically worldwide, and the damaging effects of hyperglycemia are divided into microvascular complications (diabetic nephropathy, neuropathy, and retinopathy) and macrovascular complications (coronary artery disease, peripheral artery disease, and stroke). A large number of studies have shown that monocyte/high-density lipoprotein cholesterol ratio (MHR) is an indicator of inflammation. MHR has the advantages of simple, easy to measure and stability, and may become a predictor of diabetic microangiopathy and macrovascular complications in the future. This article reviews the research progress on the role of MHR in type 2 diabetes.
出处
《临床医学进展》
2024年第7期403-407,共5页
Advances in Clinical Medicine
